• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Isolation and identification of 5-acetylamino-6-formylamino-3-methyluracil as a major metabolite of caffeine in man.

作者信息

Tang B K, Grant D M, Kalow W

出版信息

Drug Metab Dispos. 1983 May-Jun;11(3):218-20.

PMID:6135579
Abstract

An acetylated metabolite produced in man after po administration of caffeine was detected, isolated, and purified using suitable solvent extraction and chromatographic techniques. A set of UV, NMR, and mass spectral data identify it as 5-acetylamino-6-formylamino-3-methyluracil, a structure confirmed by chemical synthesis. This metabolite was shown to be unstable in the presence of dilute base and/or methanol, giving rise to a deformylated compound, 5-acetylamino-6-amino-3-methyluracil, which had recently been reported in the literature as a major metabolite of caffeine in man.

摘要

相似文献

1
Isolation and identification of 5-acetylamino-6-formylamino-3-methyluracil as a major metabolite of caffeine in man.
Drug Metab Dispos. 1983 May-Jun;11(3):218-20.
2
An alternative test for acetylator phenotyping with caffeine.
Clin Pharmacol Ther. 1987 Nov;42(5):509-13. doi: 10.1038/clpt.1987.189.
3
Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.在用于测定细胞色素P4501A2和N-乙酰转移酶-2活性时咖啡因代谢的受试者内变异分析。
Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):139-46.
4
Comparative metabolic disposition of [1-Me14C]caffeine in rats, mice, and Chinese hamsters.[1-甲基-¹⁴C]咖啡因在大鼠、小鼠和中国仓鼠体内的比较代谢情况。
Drug Metab Dispos. 1985 Jul-Aug;13(4):471-8.
5
Acetylation phenotypes and biological variation in a French Caucasian population.法国白种人群体中的乙酰化表型与生物学变异
Eur J Clin Chem Clin Biochem. 1993 Feb;31(2):59-68. doi: 10.1515/cclm.1993.31.2.59.
6
Characterization of diaminouracil metabolites of caffeine in human urine.咖啡因在人尿液中的二氨基尿嘧啶代谢产物的表征
Drug Metab Dispos. 1983 May-Jun;11(3):206-10.
7
Polymorphic N-acetylation of a caffeine metabolite.咖啡因代谢物的多态性N-乙酰化作用。
Clin Pharmacol Ther. 1983 Mar;33(3):355-9. doi: 10.1038/clpt.1983.45.
8
Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.对四种与人类乙酰化表型测定相关的尿咖啡因代谢物比率进行分离分析。
Genet Epidemiol. 1994;11(2):115-29. doi: 10.1002/gepi.1370110203.
9
Measurement of caffeine and five of the major metabolites in urine by high-performance liquid chromatography/tandem mass spectrometry.采用高效液相色谱/串联质谱法测定尿液中的咖啡因及五种主要代谢物。
J Mass Spectrom. 2005 Mar;40(3):307-16. doi: 10.1002/jms.785.
10
HPLC method for rapid determination of acetylator phenotype by measuring urinary caffeine metabolites.
J Pharm Biomed Anal. 1993 Oct;11(10):1017-21. doi: 10.1016/0731-7085(93)80063-7.

引用本文的文献

1
Association between human blood metabolome and risk of myocarditis: a mendelian randomization study.人类血液代谢组与心肌炎风险的关联:一项孟德尔随机化研究。
Sci Rep. 2024 Nov 3;14(1):26494. doi: 10.1038/s41598-024-78359-6.
2
Phytochemical characterization of and the assessment of therapeutic potential using and biological activities and studies.利用[具体方法]的生物活性及[具体研究]对[研究对象]进行植物化学特征分析及治疗潜力评估。
Front Chem. 2023 Nov 8;11:1273191. doi: 10.3389/fchem.2023.1273191. eCollection 2023.
3
Study of correlation between the NAT2 phenotype and genotype status among Greenlandic Inuit.
格陵兰因纽特人群中NAT2表型与基因型状态的相关性研究。
EXCLI J. 2018 Nov 2;17:1043-1053. doi: 10.17179/excli2018-1671. eCollection 2018.
4
Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe.使用咖啡因作为代谢探针测定希腊人群中的N-乙酰化表型。
Eur J Drug Metab Pharmacokinet. 1998 Oct-Dec;23(4):501-6. doi: 10.1007/BF03190002.
5
A simple test for acetylator phenotype using caffeine.一种使用咖啡因检测乙酰化酶表型的简单测试。
Br J Clin Pharmacol. 1984 Apr;17(4):459-64. doi: 10.1111/j.1365-2125.1984.tb02372.x.
6
The acetylator phenotypes of Saudi Arabian diabetics.沙特阿拉伯糖尿病患者的乙酰化表型
J Med Genet. 1985 Dec;22(6):479-83. doi: 10.1136/jmg.22.6.479.
7
Comparison of the urinary metabolite profile of caffeine in young and elderly males.年轻男性与老年男性咖啡因尿代谢物谱的比较。
Br J Clin Pharmacol. 1985 Feb;19(2):225-32. doi: 10.1111/j.1365-2125.1985.tb02635.x.
8
Urinary metabolites of caffeine in the premature infant.早产儿体内咖啡因的尿液代谢物
Eur J Clin Pharmacol. 1986;31(4):497-9. doi: 10.1007/BF00613531.
9
Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.乙酰化药物遗传学。慢乙酰化者表型是由人肝脏中芳胺N - 乙酰转移酶减少或缺乏所致。
J Clin Invest. 1990 Mar;85(3):968-72. doi: 10.1172/JCI114527.